Eplerenone
Eplerenone is a prescription medication that acts as an aldosterone antagonist to help manage heart failure and high blood pressure by blocking certain hormones that can raise blood pressure. Available as oral tablets in 25 mg and 50 mg strengths, manufactured by Slate Run Pharmaceuticals, LLC under ANDA212765. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Eplerenone is a prescription medication that acts as an aldosterone antagonist to help manage heart failure and high blood pressure by blocking certain hormones that can raise blood pressure. Available as oral tablets in 25 mg and 50 mg strengths, manufactured by Slate Run Pharmaceuticals, LLC under ANDA212765. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Eplerenone",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Eplerenone — ANDA 207842 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207842"
}
]
|
| identifier | ANDA207842 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-safety",
"health-care",
"medications"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Eplerenone |
